摘要 |
Compound of formula values R1-R9, and X are given in description, the pharmaceutically acceptable salts thereof, production method, pharmaceutical compositions on the basis thereof and use therapeutically effective amount thereof for treatment of disorders caused by or linked with decreased level of norepinephrine, dopamine and serotonin. |
申请人 |
AMR TECHNOLOGY, INC.;BRISTOL-MYERS SQUIBB COMPANY |
发明人 |
GUZZO, PETER, R.;SAMBANDAM, SAMBANDAM;HU, MIN;ZHA, CONGXLANG;NACRO, KASSOUM;MANNING, DAVID, D;ISHERWOOD, MATTHEW, L.;FLEMING, KRISTEN, N.;CUI, WENGE;OLSON, RICHARD, E;MOLINO, BRUCE, F.;LIU, SHUANG |